A Systematic Review of Subacute Thyroiditis Related to COVID-19

Mohammad      AlShatnawi; Mohammad       Sunoqrot; Basil      AlBakri; Mohammad      AlOqaily; Saif   Aldeen   AlRyalat

doi:10.2174/02666211213151545

Abstract

Background: The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which belongs to the family Coronaviridae, is the cause of COVID-19 infection. Its outbreak was declared a pandemic on March 11, 2020. COVID-19 does not involve the respiratory system solely, but other systems were also noted to be affected, including the endocrine, cardiovascular, and gastrointestinal systems. Several case reports and series have been published regarding SAT related to COVID-19 infection, yet management and clinical outcomes of the disease have not been discussed in detail.

Methods: This is a systematic review of cases that have been reported to have subacute thyroiditis induced by COVID-19 infection. A systematic search was conducted throughout multiple databases, including PubMed, Google Scholar, and MeSH network.

Results: The total number of reported subacute thyroiditis cases attributed to COVID-19 is 24. There was a female predominance (18 females and 6 males) with a female to male ratio of 3:1. Ages ranged from 18 to 69 years (mean = 38.67). Twenty-four symptoms related to thyroiditis were reported, the most common of which being neck pain (95.83%, n=23), palpitations (79.17%, n=19), and fever (66.67%, n=16). The outcome was complete resolution in 70% of cases.

Conclusion: The endocrine complications of COVID-19 and their management have been disregarded by most as they are rare. Our knowledge of COVID-19 and its complications is growing rapidly. More favourable outcomes were linked with the use of corticosteroid therapy. Until larger studies can be conducted, the management of SAT caused by COVID-19 remains to be based on each individual case. However, the treatment regimen should include corticosteroid therapy.

Keywords: COVID-19, De Quervain’s thyroiditis, SARS-CoV-2, Subacute thyroiditis, Thyroiditis, Viral thyroiditis.

[1] 
Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J  2020; 138577. http://pmj.bmj.com/
[2] 
Caron P. Thyroiditis and SARS-CoV-2 pandemic: A review.  Endocrine. Springer 2021; pp. 1-6.
[http://dx.doi.org/10.1007/s12020-021-02689-y] 
[3] 
Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 infection: A Case report and review of literature. Eur Thyroid J  2021; 9(6): 324-8.https://www.karger.com/Article/FullText/511872
[http://dx.doi.org/10.1159/000511872] [PMID: 33708634] 
[4] 
Subacute Thyroiditis: Practice Essentials, Pathophysiology, Etiology.  Available from:
                    https://emedicine.medscape.com/article/125648-overview
[5] 
Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute thyroiditis associated with COVID-19. Case Rep Endocrinol  2020; 2020: 8891539.
[http://dx.doi.org/10.1155/2020/8891539] [PMID: 33005461] 
[6] 
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsThe BMJ.  BMJ Publishing Group 2021; 372.
[http://dx.doi.org/10.1136/bmj.n71] 
[7] 
Álvarez Martín MC, del Peso Gilsanz C, Hernández López A. Subacute De Quervain thyroiditis after SARS-CoV-2 infection. Endocrinol Diabetes y Nutr 2020. pmc/articles/PMC7709717
[8] 
Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with Covid-19 infectionournal of Endocrinological Investigation.  Springer 2020; pp. 1173-4.
[http://dx.doi.org/10.1007/s40618-020-01316-3] 
[9] 
Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute thyroiditis after Sars-COV-2 infection. J Clin Endocrinol Metab  2020; 105(7): 2367-70.
[10] 
Chakraborty U, Ghosh S, Chandra A, Ray AK. Subacute thyroiditis as a presenting manifestation of COVID-19: A report of an exceedingly rare clinical entity. BMJ Case Rep  2020; 13(12): 239953. http://casereports.bmj.com/
[http://dx.doi.org/10.1136/bcr-2020-239953] [PMID: 33370933] 
[11] 
Chong WH, Shkolnik B, Saha B, Beegle S. Subacute thyroiditis in the setting of coronavirus disease American J Med Sci.  Elsevier B.V 2021; 361: pp. 400-2.
[12] 
Davoodi L, Oladi Z, Jafarpour H, Zakariaei Z, Soleymani E, Razavi A. A 33-year-old man with COVID-19 presented with subacute thyroiditis: A rare case report and literature review. New Microbes New Infect  2021; 100871.
[13] 
De San Juan MJ, Florencio MQ V, Joven MH. Subacute thyroiditis in a patient with coronavirus disease 2019. AACE Clin Case Reports  2019; 6(6): e361-4.
[14] 
Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case reportJournal of Endocrinological Investigation.  Springer 2020; pp. 1171-2.
[http://dx.doi.org/10.1007/s40618-020-01312-7] 
[15] 
Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep  2020; 13(8): 237336.
[http://dx.doi.org/10.1136/bcr-2020-237336] [PMID: 32843467] 
[16] 
Mehmood MA, Bapna M, Arshad M. A case of post-COVID-19 subacute thyroiditis. Cureus  2020; 12(12)
[17] 
Ruano R, Zorzano-Martinez M, Campos A, Rius F, Hernández M. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes y Nutr 2020.
[18] 
Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.  Hormones. Springer Science and Business Media Deutschland GmbH 2021; 20: pp. 219-21.
[http://dx.doi.org/10.1007/s40618-020-01312-7] 
[19] 
Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? insights from a case series. J Clin Endocrinol Metab  2020; 105(10): 1-5.
[20] 
Sohrabpour S, Heidari F, Karimi E, Ansari R, Tajdini A, Heidari F. Subacute thyroiditis in COVID-19 patients. Eur Thyroid J  2021; 9(6): 321-3.
[http://dx.doi.org/10.1159/000511707] [PMID: 33708633] 
[21] 
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. J Am Med Assoc  2020; 782-93.
[22] 
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cell  2020; 181(2): 271-80.
[23] 
Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: A review.J Infec Public Health.  Elsevier Ltd 2020; pp. 1619-29.
[24] 
Majumder J, Minko T. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19AAPS Journal.  Springer Science and Business Media Deutschland GmbH 2021; 23.
[25] 
Yotsapon T, Sirinate K, Siriwan B, Soontaree N, Thep H. Clinical features and outcomes of subacute thyroiditis in Thai patients. J ASEAN Fed Endocr Soc  2015; 30(2): 125-8.
[http://dx.doi.org/10.15605/jafes.030.02.03] 
[26] 
Alfadda AA, Sallam RM, Elawad GE, Aldhukair H, Alyahya MM. Subacute thyroiditis: Clinical presentation and long term outcome.  Int J Endocrinol  2014; 794943.
[27] 
Fatourechi V, Aniszewski JP, Fatourechi GZE, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab  2003; 88(5): 2100-5.
[http://dx.doi.org/10.1210/jc.2002-021799] [PMID: 12727961] 
[28] 
Wei L, Sun S, Xu C hong, Zhang J, Xu Y, Zhu H. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol  2007; 38(1): 95-102.
[29] 
Rotondi M, Coperchini F, Ricci G, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: A clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest  2021; 44(5): 1085-90.
[30] 
Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty  2020; 9(1): 45.
[31] 
Hennessey J V. Subacute thyroiditis Endotext 2000. Available from:
                    http://www.ncbi.nlm.nih.gov/pubmed/25905310
[32] 
Alper AT, Hasdemir H, Akyol A, Çakmak N. Incessant ventricular tachycardia due to subacute thyroiditis. Int J Cardiol  2007; 116(1): e22-4.https://pubmed.ncbi.nlm.nih.gov/17134771/
[http://dx.doi.org/10.1016/j.ijcard.2006.08.068] [PMID: 17134771] 
[33] 
Sherman SI, Ladenson PW. Subacute thyroiditis causing thyroid storm. Thyroid  2007; 17(3): 283.
[http://dx.doi.org/10.1089/thy.2007.0070] [PMID: 17381366] 